ArticlePharmaceuticals (Basel, Switzerland)2023

A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients.

Elena Campione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.